Orthopaedic Bone Cement and Casting Material Market

Orthopaedic Bone Cement and Casting Material Market Size, Market Forecast and Outlook By FMI

The orthopaedic bone cement and casting material market was valued at USD 3.2 billion in 2025. The market is set to reach USD 3.4 billion by 2026-end and grow at a CAGR of 5.3% between 2026-2036 to reach USD 5.7 billion by 2036. Bone Cement will dominate with a 53.0% share, while Joint Arthroplasty will lead with a 48.0% share.

Summary of the Orthopaedic Bone Cement and Casting Material Market

• Demand and Growth Drivers
  • Aging population demographics and increasing chronic disease prevalence are expected to support sustained demand for orthopaedic bone cement and casting material therapies across developed markets.
  • Regulatory approval of new treatment options and updated clinical guidelines are likely to expand the addressable patient population during the forecast period.
  • Expansion of healthcare insurance coverage and specialist care access in emerging markets is expected to create incremental demand channels.
• Product and Segment View
  • Bone Cement is likely to account for 53% of the product type in 2026, supported by clinical demand and treatment protocol requirements.
  • Joint Arthroplasty is expected to hold 48% of the application segment, reflecting clinical demand and treatment protocol requirements.
  • Additional segmentation reflects diversified demand patterns across application categories and geographic markets.
• Geography and Competitive Outlook
  • India is likely to remain a leading market with a projected CAGR of 5.5%, supported by established end use demand and favorable policy frameworks.
  • Japan is expected to follow at 5.3%, reflecting growing adoption and expanding market infrastructure.
  • Companies with integrated product portfolios and multi-regional distribution presence are likely to strengthen their competitive positions during the forecast period.
• Analyst Opinion
  • Nandini Roy Choudhury, Principal Consultant at FMI says, 'Companies that invest in real world evidence generation and institutional procurement relationships while maintaining differentiated clinical profiles are likely to capture disproportionate market share over the forecast period.'
  • The orthopaedic bone cement and casting material market is transitioning from a volume driven market toward one shaped by clinical evidence, outcome based pricing, and regulatory access strategies.
  • Adoption is being supported by expanding insurance coverage, aging demographics, and updated treatment guidelines across major markets.
  • Competitive dynamics increasingly favor companies with diversified product portfolios, strong regulatory affairs capabilities, and established health economics data.
  • Demand is further supported by the growing focus on personalized treatment protocols and combination therapy approaches.

Key Takeaways, Market Size, and Forecast

• The orthopaedic bone cement and casting material market was valued at USD 3.24 billion in 2025.
• By 2036, the Orthopaedic Bone Cement and Casting Material Market is expected to be worth USD 5.71 billion.
• From 2026 to 2036, the market is projected to expand at a CAGR of 5.3%.
• The market is projected to create an incremental opportunity of USD 2.30 billion between 2026 and 2036.
• In 2026, Bone Cement is expected to account for 53% of the product type, driven by clinical demand and treatment protocol requirements.
• India (5.5%) and Japan (5.3%) are two of the fastest growing markets in the world.

Orthopaedic Bone Cement and Casting Material Market Definition

The orthopaedic bone cement and casting material market encompasses pharmaceutical therapies, medical devices, and clinical interventions used in the diagnosis, treatment, and management of orthopaedic bone cement and casting material conditions. The market covers products and services delivered through hospital settings, specialty clinics, retail pharmacies, and ambulatory care centers across all major geographic regions.

Orthopaedic Bone Cement and Casting Material Market Inclusions

Market scope encompasses all commercially traded orthopaedic bone cement and casting material products categorized by Product Type (Bone Cement, Casting Materials, Others); Application (Joint Arthroplasty, Trauma Cases, Sports Injury, Spine Surgeries, Others); End User (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics); Technology (Antibiotic Impregnation Technology, High Strength Polymer Technology, Lightweight Casting Technology); Distribution Channel (Direct Sales, Distributors, Online Procurement). The revenue forecast spans 2026 to 2036.

Orthopaedic Bone Cement and Casting Material Market Exclusions

The scope does not include over the counter wellness supplements without therapeutic claims, cosmetic dermatology procedures unrelated to orthopaedic bone cement and casting material, or veterinary applications. Experimental therapies not yet in clinical trials are also excluded.

Orthopaedic Bone Cement and Casting Material Market Research Methodology

• Primary Research: FMI analysts conducted interviews with clinicians, hospital procurement managers, pharmaceutical executives, and medical device distributors across key markets.
• Desk Research: Combined data from regulatory filings, clinical trial registries, health economics databases, and manufacturer disclosures.
• Market Sizing and Forecasting: Bottom up aggregation across product type, application, end user, technology, distribution channel segments with regional adoption curves.
• Data Validation: Cross-checked quarterly against global healthcare expenditure data, regulatory approval databases, and manufacturer revenue disclosures.

Why is the Orthopaedic Bone Cement and Casting Material Market Growing?

• Demand for orthopaedic bone cement and casting material therapies is sustained by aging population demographics and the rising prevalence of chronic diseases in developed markets, with treatment volumes growing in line with demographic shifts.
• The expanding patient population that can be addressed by new therapies through regulatory approvals, together with revised clinical guidelines supporting wider adoption in different care settings.
• India led growth at 5.5% driven by expanding healthcare infrastructure, growing insurance coverage and access to specialist care.

Reimbursement schemes vary widely by market and have a direct effect on treatment uptake rates. In the USA, the volume is driven by commercial payer formulary inclusion and Medicare coverage. In Europe, health technology assessment bodies (NICE, G-BA) control access by cost effectiveness assessments. Markets with universal coverage systems, such as Japan and South Korea, have better patient access but apply price compression via government negotiated procurement. Those companies that have shown health economics evidence and real world outcome data are better positioned to more efficiently gain formulary placement.

Speed of regulatory approvals impacts competitive dynamics. The FDA’s accelerated pathways and EMA’s centralized procedures grant first mover advantages to companies that have mature clinical data packages. Orthopaedic Bone Cement and Casting Material pipeline therapies include new molecular entities and reformulated delivery systems. Clinical adoption is contingent on demonstrated improvements in efficacy over existing treatment protocols, physician familiarity with new formulations and incorporation into established treatment guidelines . Companies with strong clinical trial infrastructure and key opinion leader networks get faster uptake.

There is a clear asymmetry in pricing across treatment types. Branded drugs can be sold at a premium price in markets where there are no reference pricing constraints, while generics squeeze margins in price sensitive segments. Cost pressures are highest in public health systems with centralized procurement. Biosimilar competition is heating up and specialty pharmaceuticals are seeing their margins eroded. Those with differentiated clinical profiles and controlled distribution channels enjoy a longer pricing power than those relying on established molecules.

Market Segmentation Analysis

• Bone Cement holds 53% of the product type, reflecting established demand patterns across major markets.
• Joint Arthroplasty accounts for 48% of the application segment, supported by clinical demand and treatment protocol requirements.
• Additional segments reflect broadening demand across application categories.

The orthopaedic bone cement and casting material market is segmented by product type, application, end user, technology, distribution channel. Each segment reflects distinct demand drivers, end use requirements, and competitive dynamics that shape procurement patterns and growth trajectories.

Insights into the Bone Cement Product Type Segment

Bone cement is projected to account for 53% share of the product type segment by 2026. Demand is driven by clinical demand & treatment protocol needs. Other product type categories include Casting Materials and Others for different application needs.

The sub-categories Polymethyl Methacrylate Cement, Antibiotic Loaded Cement, Fiberglass Casting in this segment are specialized application areas. These sub-segments are indicative of the level of product differentiation and spectrum of technical requirements across end use applications.

Insights into the Joint Arthroplasty Application Segment

By 2026, Joint Arthroplasty is estimated to make up 48% of the application segment. Demand is driven by clinical demand and treatment protocol requirements. Other application categories are Trauma Cases, Sports Injury, Spine Surgeries, Others, each addressing different application requirements.

In this section sub-categories like Knee Replacement, Hip Replacement, Fracture Fixation are specialized application areas. These sub-segments indicate the level of product differentiation and the variety of technical requirements across end use applications.

Orthopaedic Bone Cement and Casting Material Market Drivers, Restraints, and Opportunities

• aging Population and Chronic Disease Prevalence is creating sustained demand for orthopaedic bone cement and casting material products across established markets.
• cost Pressure and Generic Competition constrains adoption in price sensitive segments, limiting near-term growth in emerging markets.
• expansion in Emerging Market Healthcare Infrastructure is expected to create incremental demand channels over the forecast period.

The orthopaedic bone cement and casting material market growth trajectory reflects the balance between demand expansion, cost pressures, and structural market shifts. Adoption is shaped by regulatory requirements, end use specifications, and competitive dynamics across the value chain.

Aging Population and Chronic Disease Prevalence

Demand is shaped by the expanding geriatric population across developed markets. Rising prevalence of chronic conditions increases treatment volumes and supports sustained market growth over the forecast period.

Regulatory Approvals and Clinical Guideline Updates

Growth reflects new product approvals and updated clinical treatment guidelines that expand the addressable patient population. Regulatory pathways in the USA, EU, and Japan continue to support market access for new therapies.

Cost Pressure and Generic Competition

Adoption of generic alternatives and biosimilar competition compresses margins in established therapy categories. Price sensitive public healthcare systems accelerate substitution, limiting revenue growth for branded products.

Expansion in Emerging Market Healthcare Infrastructure

Healthcare infrastructure investment in South Asia, Latin America, and the Middle East creates new demand channels. Expanding insurance coverage and specialist care access in these regions support incremental volume growth.

Analysis of Orthopaedic Bone Cement and Casting Material Market By Key Countries

Country	CAGR
India	5.5%
Japan	5.3%
Germany	3.7%
USA	2.9%
UK	2.8%

• India at 5.5% reflects expanding adoption and growing market infrastructure.
• Japan at 5.3% reflects expanding adoption and growing market infrastructure.
• Germany at 3.7% reflects expanding adoption and growing market infrastructure.
• USA at 2.9% reflects established demand infrastructure and favorable policy frameworks.

The global orthopaedic bone cement and casting material market is expected to grow at a rate of 5.3% per year from 2026 to 2036. The study covers more than 30 countries, and the main markets are listed below.

Demand Outlook for Orthopaedic Bone Cement and Casting Material Market in India

India is projected to grow at 5.5% through 2036. Growth is shaped by expanding end use demand, infrastructure investment, and policy driven adoption.

• Expanding end use applications support sustained demand growth.
• Infrastructure investment creates capacity for market expansion.
• Policy frameworks support adoption and compliance driven procurement.

Future Outlook for Orthopaedic Bone Cement and Casting Material Market in Japan

Japan is projected to grow at 5.3% through 2036. The country's aging population, high healthcare spending per capita, and structured universal coverage system support consistent demand for therapeutic products.

• Aging demographics drive sustained growth in treatment volumes.
• Universal health coverage supports broad patient access to therapies.
• Strong pharmaceutical research infrastructure supports product development.

Opportunity Analysis of Orthopaedic Bone Cement and Casting Material Market in Germany

Germany is projected to grow at 3.7% through 2036. Growth is shaped by expanding end use demand, infrastructure investment, and policy driven adoption.

• Expanding end use applications support sustained demand growth.
• Infrastructure investment creates capacity for market expansion.
• Policy frameworks support adoption and compliance driven procurement.

In-depth Analysis of Orthopaedic Bone Cement and Casting Material Market in the United States

The USA is projected to expand at 2.9% through 2036. Growth reflects an aging population base, high per capita healthcare spending, and established reimbursement frameworks that support adoption of advanced treatment protocols.

• Aging demographics support sustained demand for therapeutic interventions.
• Reimbursement policies and insurance coverage facilitate treatment access.
• Clinical trial activity and regulatory approvals accelerate product availability.

Sales Analysis of Orthopaedic Bone Cement and Casting Material Market in UK

The UK is projected to grow at 2.8% through 2036. NHS procurement frameworks and NICE guidelines shape treatment adoption, with growing investment in specialized care pathways.

• NHS procurement structures create stable demand channels for approved therapies.
• NICE evaluation guidelines influence formulary inclusion and clinical adoption.
• Expanding specialist referral networks support treatment volume growth.

Competitive Landscape and Strategic Positioning

• Stryker Corporation maintains a leading position through integrated product capabilities and established distribution relationships across major markets.
• Zimmer Biomet Holdings, Inc. and Heraeus Holding GmbH offer diversified product portfolios that include both established and emerging product categories.
• Emerging players are focusing on specialized applications and differentiated product formulations to establish market presence.

Stryker Corporation holds a leading position through integrated manufacturing capabilities and established procurement relationships with major end users. The company's product portfolio spans multiple segments, providing cross selling opportunities and customer retention advantages.

Zimmer Biomet Holdings, Inc. competes on product breadth and geographic reach. Heraeus Holding GmbH focuses on technology differentiation and specialized applications. Both companies maintain established distribution networks and customer relationships across key markets.

Barriers to entry include regulatory approval requirements, manufacturing scale, established supply chain relationships, and customer switching costs. Strategic priorities among leading companies include cost optimization, geographic expansion, product portfolio diversification, and strategic partnerships.

Key Companies in the Orthopaedic Bone Cement and Casting Material Market

Key global companies leading the orthopaedic bone cement and casting material market include:

• Stryker Corporation, Zimmer Biomet Holdings, Inc., Heraeus Holding GmbH, DJO Global Enovis maintain strong manufacturing infrastructure, established end user relationships, and broad product portfolios.
• Smith & Nephew plc, Teknimed, Exactech, Inc. have established positions through specialized product capabilities and regional distribution networks.
• Orthofix Medical Inc., BSN Medical Essity, Baxter International Inc. are establishing market presence through differentiated product formulations and targeted application focus, demonstrating potential for future market leadership.

Competitive Benchmarking: Orthopaedic Bone Cement and Casting Material Market

Company	Product Portfolio Breadth	Clinical Evidence Base	Regulatory Access	Geographic Reach
Stryker Corporation	High	High	Strong	Global
Zimmer Biomet Holdings, Inc.	High	Medium	Strong	Global
Heraeus Holding GmbH	Medium	High	Moderate	Regional
DJO Global Enovis	High	Medium	Strong	Global
Smith & Nephew plc	Medium	High	Moderate	Regional
Teknimed	High	Medium	Moderate	Regional
Exactech, Inc.	Medium	High	Low	Regional
Orthofix Medical Inc.	Low	High	Low	Regional
BSN Medical Essity	Medium	Medium	Low	Regional
Baxter International Inc.	Low	Low	Low	Regional

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Orthopaedic Bone Cement and Casting Material Market

• In 2025, Stryker Corporation expanded its orthopedic joint replacement capabilities by executing the final validation testing and clinical launch of its 3D-printed Triathlon Gold implant system, offering cementless fixation and advanced workflows across European and global healthcare markets.
• In 2025, Zimmer Biomet Holdings, Inc. launched an updated product line for its ROSA Knee robotic system, gaining USA FDA clearance for its enhanced software platform alongside the global rollout of the AI-driven WalkAI mobility application across North America and East Asia.

Key Players in the Orthopaedic Bone Cement and Casting Material Market

Major Global Players

• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Heraeus Holding GmbH
• DJO Global Enovis
• Smith & Nephew plc
• Teknimed
• Exactech, Inc.

Emerging Players/Startups

• Orthofix Medical Inc.
• BSN Medical Essity
• Baxter International Inc.

Report Scope and Coverage

Parameter	Details
Quantitative Units	USD 3.41 billion to USD 5.71 billion, at a CAGR of 5.3%
Market Definition	The orthopaedic bone cement and casting material market encompasses pharmaceutical therapies, medical devices, and clinical interventions for orthopaedic bone cement and casting material applications.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	India, Japan, Germany, USA, UK, 30 plus countries
Key Companies Profiled	Stryker Corporation, Zimmer Biomet Holdings, Inc., Heraeus Holding GmbH, DJO Global Enovis, Smith & Nephew plc, Teknimed, Exactech, Inc., Orthofix Medical Inc., BSN Medical Essity, Baxter International Inc.
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Market Segmentation Analysis

Orthopaedic Bone Cement and Casting Material Market Segmented by Product Type:

• Bone Cement
  • Polymethyl Methacrylate Cement
  • Antibiotic Loaded Cement
• Casting Materials
  • Fiberglass Casting
  • Plaster Casting
• Others

Orthopaedic Bone Cement and Casting Material Market Segmented by Application:

• Joint Arthroplasty
  • Knee Replacement
  • Hip Replacement
• Trauma Cases
  • Fracture Fixation
  • Emergency Stabilization
• Sports Injury
  • Ligament Repair
  • Soft Tissue Support
• Spine Surgeries
  • Vertebral Stabilization
  • Spinal Fusion Support
• Others

Orthopaedic Bone Cement and Casting Material Market Segmented by End User:

• Hospitals
  • Public Hospitals
  • Private Hospitals
• Ambulatory Surgical Centers
  • Day Care Orthopedic Procedures
  • Minimally Invasive Surgeries
• Orthopedic Clinics
  • Specialty Bone Clinics
  • Rehabilitation Centers

Orthopaedic Bone Cement and Casting Material Market Segmented by Technology:

• Antibiotic Impregnation Technology
  • Prophylactic Infection Control
  • Elution Based Systems
• High Strength Polymer Technology
  • Reinforced Structural Formulation
  • Fast Setting Material
• Lightweight Casting Technology
  • Composite Fiber Reinforcement
  • Rapid Hardening Systems

Orthopaedic Bone Cement and Casting Material Market Segmented by Distribution Channel:

• Direct Sales
  • Hospital Procurement Contracts
  • Tender Based Supply
• Distributors
  • Medical Equipment Distributors
  • Regional Healthcare Suppliers
• Online Procurement
  • E Healthcare Platforms
  • Manufacturer Direct Portals

Orthopaedic Bone Cement and Casting Material Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• 1. World Health Organization. (2025). Global Health Expenditure Database. WHO.
• 2. USA Food and Drug Administration. (2025). FDA Drug Approval Database: Updated Requirements. FDA.
• 3. European Medicines Agency. (2025). EMA Centralized Authorization Procedures Annual Report. EMA.
• 4. National Institutes of Health. (2025). NIH Clinical Trials Registry and Results Database. NIH.
• 5. Organisation for Economic Co-operation and Development. (2025). OECD Health Statistics 2025. OECD.

This bibliography is provided for reader reference.

This Report Addresses

• Estimating the size of the market and revenue from 2026 to 2036.
• Segmentation by product type, application, end user, technology, distribution channel.
• Insights across more than 30 country markets.
• Analysis of competitive landscape and strategic positioning.
• Assessment of market drivers, restraints, and growth opportunities.
• Investment opportunity identification across segments and regions.
• Supply chain and procurement pattern analysis.
• Delivery of data in PDF and Excel formats.